Researchers from Skoltech and their colleagues from
Hadassah Medical Center have developed hybrid nanostructured
particles that can be magnetically guided to the tumor, tracked by
their fluorescence and pushed to release the drug on demand by
ultrasound. This technology can help make cancer chemotherapy more
targeted. The paper was published in the journal Colloids and
Surfaces B: Biointerfaces.
Trackable and guided ‘nanomissiles’ deliver cancer-fighting
drug straight to the tumor
